SNS-595 and methods of using the same

Details for Australian Patent Application No. 2011201277 (hide)

Owner Sunesis Pharmaceuticals, Inc. Dainippon Sumitomo Pharma Co., Ltd.

Inventors Adelman, Daniel C.; Silverman, Jeffrey A.; Higashi, Masaru; Nakao, Satoshi

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011201277

Parent 2005222622

Filing date 22 March 2011

Wipo publication date 7 April 2011

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

Event Publications

7 April 2011 Application Open to Public Inspection

  Published as AU-A-2011201277

7 April 2011 Complete Application Filed

19 January 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Adelman, Daniel C. and Silverman, Jeffrey A.

12 April 2012 Alteration of Name

  The name of the applicant has been altered to Sunesis Pharmaceuticals, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011201278-Long lasting insulin derivatives and methods thereof

2011201276-Methods of forming a conductive transparent oxide film layer for use in a cadmium telluride based thin film photovoltaic device